Posts

Follica Announces Positive Topline Data from Clinical Study in Male Androgenetic Alopecia

Follica Announces Pilot Study for Female Pattern Hair Loss

Follica Announces Pilot Study for Female Pattern Hair Loss Published in International Journal of Women’s Dermatology

Follica, a biotechnology company developing a regenerative platform designed to treat androgenetic alopecia, epithelial ageing and other related conditions, today announced the publication of a pilot study evaluating scalp skin disruption to promote hair growth in female pattern hair loss (FPHL) in International Journal of Women’s Dermatology.

The treatment promoted hair growth over a four-month course of treatment.

The pilot study, led by Maryanne M. Senna, M.D., an assistant professor of dermatology at Harvard Medical School, enrolled 11 women with mild to moderate FPHL who had been on stable existing treatments for six or more months.

Patients underwent six treatments with the Follica proprietary Hair Follicle Neogenesis (HFN) device and application of a topical on-market drug on non-treatment days.

The scalp treatments with the HFN device, which last just a few minutes, stimulate stem cells and enable the growth of new hair follicles. A topical drug is then applied to enhance efficacy by thickening new hair follicles and hair on the scalp. The study endpoints included photographs, physician-documented Sinclair score and patient-reported improvement.

At the end of the study, 10 out of the 11 patients reported perceived improvement in hair growth and all 11 improved on their physician-graded Sinclair scores. Average improvement on the Sinclair scale, which runs from stage 1 to stage 5, was one full stage. The adverse events reported were mild and self-resolving, and all women completed the course of treatment. Although the sample size was limited, the study’s authors called the results encouraging and called for larger studies.

“Around 40 per cent of women show signs of hair loss by age 50, and for many, this starts at an earlier age. Although many women struggle with this condition, there are very few effective treatment options available, and all too often, investigational therapies are tested primarily in men,” said Dr Senna, who directs the hair loss clinic at Massachusetts General Hospital.

“This pilot study was small but encouraging, as almost all of the patients reported meaningful improvements. This was especially welcome since many of these women had tried other treatments without success. There’s a significant treatment gap for women in this field, and it’s terrific to see new approaches with the potential to close that gap. I look forward to additional research on how the Follica device could address female pattern hair loss.”

“This study demonstrates the potential of our regenerative approach at Follica, which is intended to create an embryonic window in adult skin, essentially allowing new follicles and new hair to form from epithelial stem cells. It confirms that, while our treatment may not yet be optimized for females, the mechanism of action has the potential to address both male and female androgenetic alopecia and makes clear that the device works well with longer hair as well as shorter hair,” said Jason Bhardwaj, CEO of Follica. “We’re excited to continue advancing our technology as we work to bring effective new treatment options to both men and women.”

Follica plans to advance its lead program into Phase 3 development in 2021, following a successful safety and efficacy optimization study for the treatment of hair loss in male androgenetic alopecia and a successful meeting with the Food and Drug Administration at the conclusion of the Phase 2 study.

The optimization study in male androgenetic alopecia was designed to select the optimal treatment regimen using Follica’s proprietary device in combination with a topical drug and successfully met its primary endpoint. The selected treatment regimen demonstrated a statistically significant 44 per cent improvement of non-vellus (visible) hair count after three months of treatment compared to baseline (p < 0.001, n = 19).

About Follica

Follica is a biotechnology company developing a regenerative platform designed to treat androgenetic alopecia, epithelial ageing and other related conditions. Founded by PureTech (LSE: PRTC, Nasdaq: PRTC), a co-inventor of the current platform and a group of world-renowned experts in hair follicle biology and regenerative medicine, Follica’s experimental treatment platform is designed to induce an embryonic window via a device with optimized parameters to initiate hair follicle neogenesis, the formation of new hair follicles from epithelial (skin) stem cells.

This process is enhanced through the application of a topical compound. Follica completed a safety and efficacy optimization study in 2019, and its Phase 3 registration program in male androgenetic alopecia is expected to begin in 2021. Follica’s technology is based on work originating from the University of Pennsylvania that has been further developed by Follica’s internal program. Follica’s extensive IP portfolio includes IP exclusively licensed from the University of Pennsylvania as well as Follica-owned IP.

Follica Announces Pilot Study for Female Pattern Hair Loss Published in International Journal of Women’s Dermatology

Source

Recent Posts

Follica Announces Positive Topline Data from Clinical Study in Male Androgenetic Alopecia

Follica Announces Pilot Study for Female Pattern Hair Loss

Follica Announces Pilot Study for Female Pattern Hair Loss Published in International Journal of Women’s Dermatology

Follica, a biotechnology company developing a regenerative platform designed to treat androgenetic alopecia, epithelial ageing and other related conditions, today announced the publication of a pilot study evaluating scalp skin disruption to promote hair growth in female pattern hair loss (FPHL) in International Journal of Women’s Dermatology.

The treatment promoted hair growth over a four-month course of treatment.

The pilot study, led by Maryanne M. Senna, M.D., an assistant professor of dermatology at Harvard Medical School, enrolled 11 women with mild to moderate FPHL who had been on stable existing treatments for six or more months.

Patients underwent six treatments with the Follica proprietary Hair Follicle Neogenesis (HFN) device and application of a topical on-market drug on non-treatment days.

The scalp treatments with the HFN device, which last just a few minutes, stimulate stem cells and enable the growth of new hair follicles. A topical drug is then applied to enhance efficacy by thickening new hair follicles and hair on the scalp. The study endpoints included photographs, physician-documented Sinclair score and patient-reported improvement.

At the end of the study, 10 out of the 11 patients reported perceived improvement in hair growth and all 11 improved on their physician-graded Sinclair scores. Average improvement on the Sinclair scale, which runs from stage 1 to stage 5, was one full stage. The adverse events reported were mild and self-resolving, and all women completed the course of treatment. Although the sample size was limited, the study’s authors called the results encouraging and called for larger studies.

“Around 40 per cent of women show signs of hair loss by age 50, and for many, this starts at an earlier age. Although many women struggle with this condition, there are very few effective treatment options available, and all too often, investigational therapies are tested primarily in men,” said Dr Senna, who directs the hair loss clinic at Massachusetts General Hospital.

“This pilot study was small but encouraging, as almost all of the patients reported meaningful improvements. This was especially welcome since many of these women had tried other treatments without success. There’s a significant treatment gap for women in this field, and it’s terrific to see new approaches with the potential to close that gap. I look forward to additional research on how the Follica device could address female pattern hair loss.”

“This study demonstrates the potential of our regenerative approach at Follica, which is intended to create an embryonic window in adult skin, essentially allowing new follicles and new hair to form from epithelial stem cells. It confirms that, while our treatment may not yet be optimized for females, the mechanism of action has the potential to address both male and female androgenetic alopecia and makes clear that the device works well with longer hair as well as shorter hair,” said Jason Bhardwaj, CEO of Follica. “We’re excited to continue advancing our technology as we work to bring effective new treatment options to both men and women.”

Follica plans to advance its lead program into Phase 3 development in 2021, following a successful safety and efficacy optimization study for the treatment of hair loss in male androgenetic alopecia and a successful meeting with the Food and Drug Administration at the conclusion of the Phase 2 study.

The optimization study in male androgenetic alopecia was designed to select the optimal treatment regimen using Follica’s proprietary device in combination with a topical drug and successfully met its primary endpoint. The selected treatment regimen demonstrated a statistically significant 44 per cent improvement of non-vellus (visible) hair count after three months of treatment compared to baseline (p < 0.001, n = 19).

About Follica

Follica is a biotechnology company developing a regenerative platform designed to treat androgenetic alopecia, epithelial ageing and other related conditions. Founded by PureTech (LSE: PRTC, Nasdaq: PRTC), a co-inventor of the current platform and a group of world-renowned experts in hair follicle biology and regenerative medicine, Follica’s experimental treatment platform is designed to induce an embryonic window via a device with optimized parameters to initiate hair follicle neogenesis, the formation of new hair follicles from epithelial (skin) stem cells.

This process is enhanced through the application of a topical compound. Follica completed a safety and efficacy optimization study in 2019, and its Phase 3 registration program in male androgenetic alopecia is expected to begin in 2021. Follica’s technology is based on work originating from the University of Pennsylvania that has been further developed by Follica’s internal program. Follica’s extensive IP portfolio includes IP exclusively licensed from the University of Pennsylvania as well as Follica-owned IP.

Follica Announces Pilot Study for Female Pattern Hair Loss Published in International Journal of Women’s Dermatology

Source

Recent Posts

LICHEN Professional

LICHEN Professional

Hair experts LICHEN Professional chose Cosmoprof Asia Digital Week to introduce their home-use products to the world

At Cosmoprof Asia Digital Week, the first ever digital edition of the region’s most renowned annual cosmetics and beauty event, LICHEN Professional responded to the current trend of home-use products with their hair colour and anti-hair loss products.

Super fast colour

With hairdressers currently unable to operate in some parts of the world, Lichen’s hair colour shampoo is the ideal stand in for those with black or brown hair. So easy to apply at home, it takes only five minutes to cover the hair with a colour that will last up to four weeks. As well as colouring the hair, the shampoo strengthens and nourishes each and every strand, as well as the roots. Once rinsed and dried, the hair looks shiny, feels silky and, just as importantly, boosts inner confidence once again.

Hair repair for anti-hair loss

Lichen’s Anti-Hair Loss Treatment is a combination of shampoo, conditioner, hair mask and hair oil. The 4-in-1 product makes it easy for anyone to stop having to worry about hair loss. Starting with a deep repair to the damaged hair, the product works to increase the health of the entire hair thanks to active precious plant essences as well as ingredients such as vitamin E, collagen and vitamin B5. The hair finish is nourished and moisturised on the inside and smooth, soft and bright on the outside.

About LICHEN Professional

Founded in 2010, Guangzhou LICHEN Cosmetic Co., Ltd is headquartered near the southern Chinese city’s airport. Focused on providing OEM hair care, LICHEN offers hair colour shampoo, as well as shampoo, conditioner, styling and treatment products. The company also works with clients on customised formulas for various requirements.

Comprising an FDA and ISO certified factory of 12,000 square meters, the company’s manufacturing space includes nine automatic process lines and a 400-square-meter lab, dedicated to ensuring the products that leave the factory are of the highest standard. The fast production line can handle minimum order quantities of testing trial orders as well as large-scale requests.

Lichen follows international standards throughout the process, and exports products to about 50 countries’ supermarkets, pharmacies, salons and stylists as well as to online stores. The company prides itself on its guarantee of quality, professional sales and after-sales services, and a team that creates these products with passion, efficiency and conscientiousness.

For product enquiry, please contact Anne Tang at 86-13538739819 or send an email to sales@lichenhaircolor.com.

About Cosmoprof Asia Digital Week

The first-ever edition of Cosmoprof Asia Digital Week has concluded successfully, creating copious business opportunities for the world’s companies and operators looking for new business solutions in the Asia-Pacific region.

652 exhibitors from 19 countries and regions took part in the event. 8,953 visitors from 115 countries and regions registered on the platform in order to virtually network, learn about current and upcoming trends. Cosmoprof Asia Digital Week offered a vital virtual business arena for the whole beauty industry while we are all waiting to meet again in Hong Kong in November 2021 for Cosmoprof Asia. Stay tuned for updates.

Hair experts LICHEN Professional chose Cosmoprof Asia Digital Week to introduce their home-use products to the world

Source

Recent Posts

Hair Loss Supplement Market

Hair Loss Supplement Market

Global Hair Loss Supplement Market Status

The report forecast global Hair Loss Supplement market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation.

The report offers detailed coverage of Hair Loss Supplement industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Hair Loss Supplement  by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

First, this report covers the present status and the future prospects of the global Hair Loss Supplement market for 2015-2024.

And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland],

North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].

At the same time, we classify Hair Loss Supplement according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.

Finally, the report provides detailed profile and data information analysis of leading Hair Loss Supplement company.

Key Content of Chapters as follows (Including and can be customized) :
Part 1:
Market Overview, Development, and Segment by Type, Application & Region
Part 2:
Company information, Sales, Cost, Margin etc.
Part 3:
Global Market by company, Type, Application & Geography
Part 4:
Asia-Pacific Market by Type, Application & Geography
Part 5:
Europe Market by Type, Application & Geography
Part 6:
North America Market by Type, Application & Geography
Part 7:
South America Market by Type, Application & Geography
Part 8:
Middle East & Africa Market by Type, Application & Geography
Part 9:
Market Features
Part 10:
Investment Opportunity
Part 11:
Conclusion

Market Segment as follows:

By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]

Key Companies
Nutrafol(US)
Komplete Balance(US)
ArtNaturals(US)
Lia Wellness, Inc.(US)
BioProsper Labs(US)
Naturenetics Inc.(US)
Nature’s Wellness(US)
Nourish Beaute(US)
Pure Results Nutrition(US)

Market by Type
Tablets
Capsules
Others

Market by Application
Individuals
Clinics
Others

Global Hair Loss Supplement Market Status

Source

Recent Posts

Global Scalp Microneedling Market 2020 to 2028

Global Scalp Microneedling Market 2020 to 2028

Global Scalp Microneedling Market 2020 to 2028

Microneedling involves the use of a skin roller with small needles that causes minor skin injuries. While used as an anti-aging skin treatment, microneedling may also be a method of treatment for hair loss. The same process of creating wounds in the skin is also thought to regenerate the health of the hair follicles.

While microneedling revs up collagen production in the scalp just like it does on the face, it also brings blood flow and nutrients to the scalp and induces new stem cells that support hair growth.

The Scalp Microneedling market was valued at xx Million US$ in 2020 and is anticipated to reach xx Million US$ by 2028, at a CAGR of xx% during the forecast period. In this study, 2020 has been considered as the base year and 2020 to 2028.

The recently released report by Report Consultant titled Global Scalp Microneedling Market is a detailed analogy that gives readers an insight into the intricacies of several elements such as growth rate, technological developments, and impact of socio-economic conditions that affect the market space. A detailed study of these numerous components is essential as all these aspects need to blend-in seamlessly for Market to achieve success in this industry.

Global Scalp Microneedling Market Key players:-

  • Yonghe Hair Transplant
  • zcalp
  • Lotus

Competitive information detailed in the Scalp Microneedling market report has been based on innovative product launches, distribution channels, local networks, industrial penetration, production methods, and revenue generation of each market player. Furthermore, growth strategies and mergers & acquisitions (M&A) activities associated with the players are enclosed in the Scalp Microneedling market report.

Due to the pandemic, we have included a special section on the Impact of COVID 19 on the market which would mention How the Covid-19 is affecting the Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Covid-19 Impact on Key Regions and Proposal for Scalp Microneedling Market Players to Combat Covid-19 Impact.

Global Scalp Microneedling Market by Type:-

  • Under 0.25 mm
  • 0.25mm-0.3mm
  • 1.0mm-1.5mm
  • Above 1.5mm

Global Scalp Microneedling Market by Application:-

  • Hair Transplant
  • Boost Hair
  • Others

Geography of Global Scalp Microneedling Market:-

  • North America
  • Europe
  • Asia Pacific
  • Middle East
  • Latin America

Global Scalp Microneedling Market report provides a strong understanding of the current state of competition, major opportunities, regulations & strategies impacting the market. Report has been studied using tools such as SWOT Analysis and Porter’s Five Forces. Thus, this analysis document can facilitate all the business players and also the readers having a keen interest within the development of this market.

Global Scalp Microneedling Market Report Table of Contain (TOC):-

  1. Global market overview
  2. Market competition by manufacturers, type and application
  3. USA/China/Japan/Europe/India and Southeast Asia are the regional analysis of Scalp Microneedling Market (volume, value and sales price)
  4. Analysis of the global market by the manufacturer
  5. Global Scalp Microneedling Market manufacturing cost analysis
  6. Industrial Chain, sourcing strategy and downstream buyers
  7. Marketing strategy analysis, distributors/traders
  8. Market effect factors analysis
  9. Global market forecast 2020-2028
  10. Conclusion of the Global Scalp Microneedling Market
  11. Appendix

About Us:

Report Consultant – A worldwide pacesetter in analytics, research and advisory that can assist you to renovate your business and modify your approach. With us, you will learn to take decisions intrepidly by taking calculative risks leading to lucrative businesses in the ever-changing Market. We make sense of drawbacks, opportunities, circumstances, estimations and information using our experienced skills and verified methodologies.

Our research reports will give you the most realistic and incomparable experience of revolutionary Market solutions. We have effectively steered businesses all over the world through our Market research reports with our predictive nature and are exceptionally positioned to lead digital transformations. Thus, we craft greater value for clients by presenting progressive opportunities in the global futuristic Market.

Global Scalp Microneedling Market 2020 to 2028

Source

Recent Posts

Ovation Hair Continues to Support Children in Need

Ovation Hair Continues to Support Children in Need

Ovation Hair® Continues to Support Children in Need through the Local Marine Toys for Tots® Program

The Season of Giving Has Arrived at Ovation Hair Headquarters

D.C. Labs, a nationwide provider of the luxurious Ovation Cell Therapy Hair & Scalp Treatment, kicks off another holiday season encouraging team members to support the local Toys for Tots Program. The team behind the scenes at Ovation Hair are definitely feeling the gift-giving spirit.

Collection bins were set up at the San Diego headquarters, where team members generously donated toys, games and books to be gifted to those less fortunate.

Dallas Van Kempen, owner and CEO of Ovation Hair, encourages employees to donate by entering each donor into a raffle for prizes. “Year after year, we look forward to lending our support to this important cause,” Mr Van Kempen explains, “This year has been difficult for everyone – especially the children. These children are in our thoughts and so very deserving of our support. We are happy to contribute whatever we can.”

“As the holidays arrive, we’re reminded how important it is to be a contributing member of our communities,” states Len Conner, General Manager of Ovation Hair, “We’re proud to continue the annual tradition and support our local Toys for Tots Foundation.”

To learn more about Ovation Hair go to http://www.ovationhair.com.

About Toys for Tots:

Toys for Tots, a national charitable program run by the U.S. Marine Corps Reserve, provides happiness and hope to less fortunate children during each Christmas holiday season. The toys, books and other gifts collected and distributed by the Marines offer these children recognition, confidence and a positive memory for a lifetime.

It is such experiences that help children become responsible citizens and caring members of their community. The Marine Toys for Tots Foundation is a not-for-profit organization authorized by the U.S. Marine Corps and the Department of Defense to provide fundraising and other necessary support for the annual Marine Corps Reserve Toys for Tots Program. For more information, visit http://www.toysfortots.org.

About Ovation Hair®

The philosophy of Ovation Hair is to meet clients’ high expectations with quality, nourishing and rejuvenating products that demonstrate proven effectiveness. Ovation Hair has been helping clients achieve healthy hair since 2007. Their flagship product, Ovation Cell Therapy is proven to deliver thicker, stronger, longer hair.

Ovation products include high-quality ingredients, demonstrated to be safe and effective to create healthy hair. For more information please visit https://www.ovationhair.com

Ovation Hair® Continues to Support Children in Need through the Local Marine Toys for Tots® Program

Source

Recent Posts

Hair Transplant Market

Hair Restoration Services Market

Hair Restoration Services Market

The global hair restoration services market was valued at $8,452.5 million in 2018 and is projected to reach $12,119.4 million by 2026, growing at a CAGR of 4.6% from 2019 to 2026. The rise in bald population around the globe has been a major driving factor of the global hair restoration services market.

The global hair restoration services market is segmented based on service type, gender, service provider, and region. On the basis of service type, the market is categorized into follicular unit extraction, follicular unit transplantation, laser treatment, follicular unit strip surgery, and others. In terms of gender, the market is fragmented into male and female. By service provider, it is segregated into hospitals, clinics, and surgery centre.

Over the past couple of years, hair loss has been a rising concern in some of the major parts of the world, specifically in North America, Europe, and Asia-Pacific. As per AMR sources, nearly 50 million men and 30 million women in the U.S. suffer from hair loss. In Europe, the Czech Republic has the highest number of bald individuals, with the male population accounting for more than 50%. Similarly, in India, the majority of the male population especially in their 20s have been tackling with baldness issue. With the rise in concern over hair loss, the consumer seeks relevant solution or treatment on a long-term basis. This one factor has led to increasing in demand for hair restoration services.

Over the last decade, hair restoration services have evolved in terms of technology and efficiency. Several key hair restoration service providers have been strategizing on evolving and improvising their services, which has resulted in increased customer demand for an upgraded version of several hair restoration solutions, specifically follicular unit extraction and follicular unit transplantation.

Many hair restoration patients subject themselves to unnecessary risk, and in some cases, permanent harm, by unknowingly having their procedures done by unlicensed techs who illegally perform surgery, rather than licensed and appropriately experienced professionals. The rogue clinics that facilitate illegal practices have created an expanding black-market hair transplant. Patients around the world are suffering from the unlawful actions of these clinics, which could significantly impair the entire hair transplant industry.

According to the U.S. Census Bureau, millennials are on the verge of surpassing baby boomers in the country.

Similarly, in Asia-Pacific, millennials account for a larger population, especially in countries such as China, India, and Australia as compared to other population groups. Moreover, hair loss concerns have been high among the millennials, specifically in North America and Europe. Hence, they consider hair restoration services as a solution on a long-term basis. Thus, the rise in the millennial population is antedated to provide immense opportunity for hair restoration services, in terms of value sales.

Key players profiled in the report include Direct Hair Implantation International, iGrow Laser, Bosley Inc., Elite Hair Restoration, National Hair Centers, NeoGraft, Lexington Intl., LLC, Bernstein Medical, Cole Hair Transplant Group, and others.

KEY BENEFITS FOR STAKEHOLDERS

• The report provides an extensive analysis of the current and emerging trends and opportunities in the global hair restoration services market.
• The report provides a detailed qualitative and quantitative analysis of current trends and future estimations that help to evaluate the prevailing market opportunities.
• A comprehensive analysis of the factors that drive and restrict the growth of the market is provided.
• An extensive analysis of the market is conducted by following key product positioning and monitoring the top competitors within the market framework.
• The report provides extensive qualitative insights on the potential segments or regions exhibiting favourable growth.

KEY MARKET SEGMENTS

By Service Type

• Follicular Unit Extraction
• Follicular Unit Transplantation
• Laser Treatment
• Follicular Unit Strip Surgery
• Others

By Gender

• Male
• Female

By Service Provider

• Hospital
• Clinic
• Surgery Center

By Region

• North America
o U.S.
o Canada
o Mexico

• Europe
o UK
o Germany
o France
o Italy
o Spain
o Russia
o Rest of Europe

• Asia-Pacific
o China
o India
o Japan
o Australia and New Zealand
o Rest of Asia-Pacific

• LAMEA
o Latin America
o Middle East
o Africa

Hair Restoration Services Market

Source

Recent Posts

Hair Loss Supplement Market Report

Global Hair Loss Medications Industry

Global Hair Loss Medications Industry Market Research Report

The Hair Loss Medications market revenue was xx.xx Million USD in 2015, grew to xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2026.

Based on the Hair Loss Medications industrial chain, this report mainly elaborates on the definition, types, applications and major players of Hair Loss Medications market in details.

Deep analysis about market status (2016-2019), enterprise competition pattern, advantages and disadvantages of enterprise Products, industry development trends (2020-2026), regional industrial layout characteristics and macroeconomic policies, industrial policy has also be included.

From raw materials to downstream buyers of this industry will be analyzed scientifically, the feature of product circulation and sales channel will be presented as well. In a word, this report will help you to establish a panorama of industrial development and characteristics of the Hair Loss Medications market.

The Hair Loss Medications market can be split based on product types, major applications, and important regions.

Major Players in Hair Loss Medications market are:

Keranique
Johnson & Johnson
Merck
Pharma Medico
Oxford BioLabs
Phyto Ales Group
Kirkland Signature
Bayer
DS Healthcare Group
Gerolymatos International
Amplixin
Ultrax Labs
Nanogen

Major Regions play vital role in Hair Loss Medications market are:

North America
Europe
China
Japan
Middle East & Africa
India
South America
Others

Most important types of Hair Loss Medications products covered in this report are:

Type 1
Type 2
Type 3
Type 4
Type 5

Most widely used downstream fields of Hair Loss Medications market covered in this report are:

Homecare
Hair Loss Treatment Clinic

There are 13 Chapters to thoroughly display the Hair Loss Medications market. This report included the analysis of market overview, market characteristics, industry chain, competition landscape, historical and future data by types, applications and regions.

Chapter 1: Hair Loss Medications Market Overview, Product Overview, Market Segmentation, Market Overview of Regions, Market Dynamics, Limitations, Opportunities and Industry News and Policies.

Chapter 2: Hair Loss Medications Industry Chain Analysis, Upstream Raw Material Suppliers, Major Players, Production Process Analysis, Cost Analysis, Market Channels and Major Downstream Buyers.

Chapter 3: Value Analysis, Production, Growth Rate and Price Analysis by Type of Hair Loss Medications.

Chapter 4: Downstream Characteristics, Consumption and Market Share by Application of Hair Loss Medications.

Chapter 5: Production Volume, Price, Gross Margin, and Revenue ($) of Hair Loss Medications by Regions (2016-2019).

Chapter 6: Hair Loss Medications Production, Consumption, Export and Import by Regions (2016-2019).

Chapter 7: Hair Loss Medications Market Status and SWOT Analysis by Regions.

Chapter 8: Competitive Landscape, Product Introduction, Company Profiles, Market Distribution Status by Players of Hair Loss Medications.

Chapter 9: Hair Loss Medications Market Analysis and Forecast by Type and Application (2020-2026).

Chapter 10: Market Analysis and Forecast by Regions (2020-2026).

Chapter 11: Industry Characteristics, Key Factors, New Entrants SWOT Analysis, Investment Feasibility Analysis.

Chapter 12: Market Conclusion of the Whole Report.

Chapter 13: Appendix Such as Methodology and Data Resources of This Research.

Global Hair Loss Medications Industry Market Research Report

Source

Recent Posts

Global OTC Hair Loss Treatment

2015-2025 Global OTC Hair Loss Treatments Market Research

Summary

The global OTC Hair Loss Treatments market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.

Further key aspects of the report indicate that:
Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size
Chapter 2: Global Production & Consumption Market by Type and End-Use
Chapter 3: Europe Production & Consumption Market by Type and End-Use
Chapter 4: America Production & Consumption Market by Type and End-Use
Chapter 5: Asia Production & Consumption Market by Type and End-Use
Chapter 6: Oceania Production & Consumption Market by Type and End-Use
Chapter 7: Africa Production & Consumption Market by Type and End-Use
Chapter 8: Global Market Forecast by Type, End-Use and Region
Chapter 9: Company information, Sales, Cost, Margin, news etc.
Chapter 10: Market Competition by Companies and Market Concentration Ratio
Chapter 11: Market Impact by Coronavirus.
Chapter 12: Industry Summary
.
Market Segment as follows:

Key Companies
Merck
J&J
Taisho Pharma
Costco Wholesale
Wal-Mart
Bayer
Zhejiang Wansheng Pharma
Sichuan Medco Huakang Pharma
Zhendong Anter
DrFormulas
Renata
Dr.R.PFLEGER
DS Healthcare Group

Key Types

Minoxidil
Procapil
Others

Key End-Use

Male
Female
Both

This report can be dispatched within 24-48 Hours.

2015-2025 Global OTC Hair Loss Treatments Market Research

Source

Recent Posts

Hair Transplant Market

Competitive Outlook of Hair Transplantation

Strategic Analysis to Understand the Competitive Outlook of Hair Transplantation informational report Market

Prophecy Market Insights has recently published the Hair Transplantation informational report which evaluates market size, growth rate, profit margin, raw material availability, impact strength, competition, technology, and environmental and legal factors.

The report covers all recent trends, opportunities, drivers, and restraints of the Hair Transplantation market coupled with their impact on demand over the forecast period. Additionally, the report provides a comprehensive view of the market by offering exhaustive value chain analysis. It provides in-depth information about value addition at each stage of the value chain.

Market Overview

·       Stakeholders and readers can find the definition and a detailed taxonomy of the market, which will help them to understand basic information about the market.

·       Comprehensive information pertaining to fire alarm systems and its properties is provided in this section. This section also highlights the inclusions and exclusions, which help readers to understand the scope of the market report.

Executive Summary

The executive summary of the market, which includes a summary of key findings and statistics of the market. It also includes demand and supply-side trends pertaining to this market.

Key Trends & other factors

·       The market report provides key market trends that are expected to significantly impact market growth during the forecast period. Detailed industry trends are also provided in this section.

·       This segment includes factors that have emerged as key success factors and strategies adopted by key market participants.

The Hair Transplantation market report provides a detailed analysis of market players according to its production footprint, market share, and growth rate.

The report also covers SWOT analysis (strengths, weaknesses, opportunities, and threats) of the players. Besides, the Hair Transplantation market study depicts the recent launches, R&D projects, agreements, and business strategies of the market players including market segmentation and regional analysis of the market.

The Hair Transplantation market study covers both the top-down and bottom-up approaches that have been used to calculate and authenticate the market size and estimate the scenario of various sub-markets in the global market. The report estimation size of the market both in terms of volume (x units) and value (Mn/Bn USD).

Hair Transplantation Market by Top Manufacturers:

  • Dermis Health Private Limited
  • Acibadem Hospitals Group
  • NeoGraft
  • The Private Clinic
  • Bernstein Medical
  • Advanced Hair Restoration
  • Limmer Hair Transplant Center
  • Bosley – Hair Restoration & Transplant
  • Mosaic Clinic Hair Transplant Center
  • Hair Transplants of Florida.

Scope of the Market Research Report:

  • Chapter 1 : Table of Contents
  • Chapter 2: Market Purview
  • Chapter 3: Market Dynamics
  • Chapter 4: Segmentation
  • Chapter 7: Region
  • Chapter 8: Competitive Analysis
  • Chapter 9: Company Profiles
  • Investment Outlook
  • Future of the Market

The report takes into account the impact of the novel COVID-19 pandemic on the market and provides a clear assessment of the estimated market fluctuations throughout the forecast period.

Important Questions Answered in Hair Transplantation Market Report:

  • Breakdown data at the regional level of the Hair Transplantation market
  • Scrutinized data on the basis of the country, including market revenue and share of the important countries.
  • Distribution channels and consumption patterns of the Hair Transplantation market
  • Critical analysis of each market player, such as, acquisitions, collaborations, and product launches.
  • Trends influencing the growth of the Hair Transplantation market including regulatory norms, ecological preservation, and R&D developments.

Segmentation Overview:

  • By Method (Follicular Unit Extraction and Follicular Unit Transplantation)
  • By Type of Surgery (Eyebrow Transplant, Head Hair Transplant, Frontal Hair Line Lowering or Reconstruction and Others)
  • (Hospitals, Dermatology Clinics and Trichology Clinics)

Reasons to purchase the XYX market:

  • Investigates Hair Transplantation Market thoroughly and includes present status and future estimations of the market.
  • Detail analysis of segments, sub-segments, and environmental markets for understanding market expansion.
  • Provides ten-year forecast prediction on how the Hair Transplantation market is estimated to grow.

Provides recent collaborations, mergers, acquisitions, and partnerships along with regulatory framework across vast regions impacting the market trajectory

Strategic Analysis to Understand the Competitive Outlook of Hair Transplantation informational report Market

Source

Recent Posts

Hair Loss Treatment Industry Market

Hair Loss Treatment Products Market

Global Hair Loss Treatment Products Market

The Hair Loss Treatment Products market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Hair Loss Treatment Products market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Hair Loss Treatment Products market.

The report focuses on well-known providers in the global Hair Loss Treatment Products industry, market segments, competition, and the macro environment.

Under COVID-19 Outbreak, how the Hair Loss Treatment Products Industry will develop is also analyzed in detail in Chapter 1.7 of the report.

In Chapter 2.4, we analyzed industry trends in the context of COVID-19.

In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.

In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.

In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Key players in the global Hair Loss Treatment Products market covered in Chapter 4:

VLCC
Pantene
L’Oreal
Sebamed
The Himalaya Drug Company
Kama Ayurveda
Trichup Hair Care
Mamaearth
Organic Harvest
BIOTIQUE

In Chapter 11 and 13.3, on the basis of types, the Hair Loss Treatment Products market from 2015 to 2026 is primarily split into:

Hair Loss and Growth Devices
Shampoos and Conditioners
Medicine Product
Others

In Chapter 12 and 13.4, on the basis of applications, the Hair Loss Treatment Products market from 2015 to 2026 covers:

Supermarkets and Hypermarkets
Convenience Stores
Specalist Retailers
Pharmacies
Online Retail
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:

North America (Covered in Chapter 6 and 13)

United States

Canada

Mexico

Europe (Covered in Chapter 7 and 13)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 8 and 13)

China

Japan

South Korea

Australia

India

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 9 and 13)

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Others

South America (Covered in Chapter 10 and 13)

Brazil

Argentina

Columbia

Chile

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2026

Global Hair Loss Treatment Products Market

Source

Recent Posts